IRTC vs. AXNX, PRCT, MMSI, HAE, IART, ICUI, NARI, TNDM, GKOS, and ATEC
Should you be buying iRhythm Technologies stock or one of its competitors? The main competitors of iRhythm Technologies include Axonics (AXNX), PROCEPT BioRobotics (PRCT), Merit Medical Systems (MMSI), Haemonetics (HAE), Integra LifeSciences (IART), ICU Medical (ICUI), Inari Medical (NARI), Tandem Diabetes Care (TNDM), Glaukos (GKOS), and Alphatec (ATEC). These companies are all part of the "surgical & medical instruments" industry.
Axonics (NASDAQ:AXNX) and iRhythm Technologies (NASDAQ:IRTC) are both mid-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, institutional ownership, community ranking, dividends, valuation, analyst recommendations, profitability, media sentiment and risk.
99.5% of Axonics shares are owned by institutional investors. 1.9% of Axonics shares are owned by insiders. Comparatively, 0.7% of iRhythm Technologies shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.
Axonics has a net margin of -1.66% compared to Axonics' net margin of -25.05%. iRhythm Technologies' return on equity of -1.00% beat Axonics' return on equity.
Axonics presently has a consensus price target of $70.73, indicating a potential upside of 6.07%. iRhythm Technologies has a consensus price target of $135.11, indicating a potential upside of 15.19%. Given Axonics' stronger consensus rating and higher possible upside, analysts plainly believe iRhythm Technologies is more favorable than Axonics.
Axonics has higher earnings, but lower revenue than iRhythm Technologies. Axonics is trading at a lower price-to-earnings ratio than iRhythm Technologies, indicating that it is currently the more affordable of the two stocks.
In the previous week, Axonics had 1 more articles in the media than iRhythm Technologies. MarketBeat recorded 3 mentions for Axonics and 2 mentions for iRhythm Technologies. iRhythm Technologies' average media sentiment score of 1.82 beat Axonics' score of 0.93 indicating that Axonics is being referred to more favorably in the media.
iRhythm Technologies received 213 more outperform votes than Axonics when rated by MarketBeat users. However, 67.18% of users gave Axonics an outperform vote while only 65.93% of users gave iRhythm Technologies an outperform vote.
Axonics has a beta of 0.56, meaning that its share price is 44% less volatile than the S&P 500. Comparatively, iRhythm Technologies has a beta of 1.3, meaning that its share price is 30% more volatile than the S&P 500.
Summary
Axonics beats iRhythm Technologies on 11 of the 18 factors compared between the two stocks.
Get iRhythm Technologies News Delivered to You Automatically
Sign up to receive the latest news and ratings for IRTC and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding IRTC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartThis chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
iRhythm Technologies Competitors List
Related Companies and Tools